Expanded Access of Ruxolitinib Cream to Treat a Single Patient With cGVHD
Clinical trial NCT05722912 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT05722912
- Sponsor
- Incyte Corporation
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.